Overview

Clinical Trial of the Seaweed Supplement Fucoidan in Survivors of Cancer

Status:
RECRUITING
Trial end date:
2026-04-15
Target enrollment:
Participant gender:
Summary
To determine the feasibility of an 8-week fucoidan supplement intervention for patients with fatigue post-cancer treatment and assess changes in fatigue, frailty, and inflammation.
Phase:
PHASE2
Details
Lead Sponsor:
University of Rochester
Collaborator:
National Cancer Institute (NCI)